First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - PHARMA STRATEGY GROUP LIMITED

ANALYSIS
Credit Risk Update: PHARMA STRATEGY GROUP LIMITED, 3 FORBURY PLACE, 23 FORBURY ROAD, READING, RG1 3JH. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2023. The company was incorporated on 20 February 1973.

The accounts next due date is 30 September 2025. There is 1 mortgage, which is satisfied

The above was based on public record information as at 22 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 01097237
Date Incorporated: 20 February 1973
Date Latest Accounts: 31 December 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 01097237
Annual Return: 30 April 2016
Registered Office: 3 FORBURY PLACE, 23 FORBURY ROAD, READING, RG1 3JH
SIC Code and Operations: 74990
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 1
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMA STRATEGY GROUP LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 1 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
11092060 PHARMA STRATEGY LTD Active
11183138 PHARMA STUDY LIMITED Active - Proposal to Strike off
09411665 PHARMA SUPPLIES LTD Active - Proposal to Strike off
12576888 PHARMA SUPPLIES LTD Active - Proposal to Strike off
12439640 PHARMA SUPPLY CHAIN EXCELLENCE LTD Liquidation

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd